Ata Salabati, MD

Ophthalmology PGY4 @VCUhealth, Former Researcher @Wills_eye @MidAtl_Retina, Passionate about Retina, Research, and Resident Education.

[Ata Salabati, MD @AtaSalabati]

Please check out our new paper on sickle cell retinopathy, just published in @RetinalPhys

[Retinal Physician @RetinalPhys]

Jessica D. Randolph, MD, and colleagues discuss how imaging advances and systemic therapies are redefining care for sickle cell retinopathy. Read more: https://t.co/caYeCYwcWq
#RetinalPhysician #retinasurgery #sicklecell #SCR #clinicaltrials #Conexiant

[Retinal Physician @RetinalPhys]

The October issue, with a focus on inherited retinal diseases and gene therapy, is now available at: https://t.co/ggxqHmHBKF
#RetinalPhysician #retinasurgery #IRD #RP #Stargardt #XLRS #XLRP #genetherapy #optogenetics #clinicaltrials #Conexiant

[Ata Salabati, MD @AtaSalabati]

Our recent publication in JVRD @asrsdocs. Despite greater fluid & thicker retinas, patients needing frequent anti-VEGF injections achieved similar visual gains to those treated less often. Baseline VA remained the strongest predictor. @MidAtl_Retina.
https://t.co/D35bukQCVL

[Raziyeh Mahmoudzadeh, MD @RaziyehMahmoud1]

Please check out our new paper just published @JAMAOphth
@ Mariam Sameul @WhiteCoatWhee @AtaSalabati @ChrisLefflerMD @eyeballsurgeon @VCUHealth #COVID #Covid_19 #Ophthalmology #eye

[JAMA Ophthalmology @JAMAOphth]

The #COVID-19 pandemic reduced the number of common ophthalmic procedures among #Medicare beneficiaries in 2020, with notable geographic disparities. https://t.co/T8ECSyQTrf

[Retina @RetinaJournal]

OUTCOMES OF PRO RE NATA VERSUS TREAT-AND-EXTEND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR MYOPIC MACULAR NEOVASCULARIZATION IN MULTIETHNIC PATIENTS IN THE UNITED STATES
Swaminathan, Shreya BS; et. al.
#Retina 44(12):p 2057-65, Dec 2024
https://t.co/wfK30WMVIZ

[Ata Salabati, MD @AtaSalabati]

I had the privilege of contributing to "A New History of Cataract Surgery", co-authoring a chapter alongside the great @ChrisLefflerMD. Honored to be part of this project. #Ophthalmology #CataractSurgery

https://t.co/3wra1TgnzF

[Ata Salabati, MD @AtaSalabati]

Excited to be a co-author in this amazing project! Check out "Biographies of Ophthalmologists from Around the World: Ancient, Medieval, and Early Modern" by @ChrisLefflerMD.
https://t.co/DcywcCW2OM

[Chris Leffler @ChrisLefflerMD]

Biographies of Ophthalmologists from Around the World: Ancient, Medieval, and Early Modern. by 12 Contributors. 384 pages softcover. Free w/ Kindle Unlimited (or $2.99 w/o). Has archival documents. Lots of new research. #Ophthalmology #History https://t.co/GQvEYedsxa

[Ata Salabati, MD @AtaSalabati]

@michelabecarnou I am not aware of that. Such a huge loss.

[Ata Salabati, MD @AtaSalabati]

Devastated to hear about the loss of Dr. Ramin Tadayoni, a distinguished retina specialist. Had the pleasure to meet him in Iran, a true gentleman. My deepest condolences to his family and colleagues. His legacy will endure.

[Ata Salabati, MD @AtaSalabati]

@elyadekrami @FutureAnesRes @OutcomesRC Congrats!

[Ata Salabati, MD @AtaSalabati]

@smsaadatagah @ShahriarFaghani Congrats Shahriar!

[Ata Salabati, MD @AtaSalabati]

https://t.co/UJ3jT47xcT

[Wills Eye Hospital @Wills_Eye]

Drs. @garg_sunir and @JasonHsuMD spoke with @medpagetoday about a study out of Wills Eye Hospital and @MidAtl_Retina regarding pausing anti-VEGF injections in patients with advanced wet AMD.

Read about the findings:

https://t.co/bdRmXxuNVk

[Wills Eye Hospital @Wills_Eye]

Drs. @garg_sunir and @JasonHsuMD spoke with @medpagetoday about a study out of Wills Eye Hospital and @MidAtl_Retina regarding pausing anti-VEGF injections in patients with advanced wet AMD.

Read about the findings:

https://t.co/bdRmXxuNVk

[Jason Hsu @JasonHsuMD]

Important paper exploring effects of VA measurement method (Snellen vs ETDRS) on magnitude of change in vision over course of clinical trials. Implications for interpreting real world data vs trials. @AtaSalabati @TXRetinaSurgeon @Wills_Eye https://t.co/nl54UgvAY4

[Ata Salabati, MD @AtaSalabati]

Our case series on RRD repair outcomes in patients with nystagmus is out! Kudos to Ava Torjani and a big thank you to @NJRetinaDoc for guidance! Published in @RetinaJournal cases and brief reports.@AbtinShahlaee @RaziyehMahmoud1. @Wills_Eye @MidAtl_Retina
https://t.co/InS0SSwQFM

[Ata Salabati, MD @AtaSalabati]

Our recent study published at JVRD @asrsdocs compares different treatment modalities for patients with RAM who presented with vitreous hemorrhage! A great team effort led by Sophia Lam, @AbtinShahlaee and @NJRetinaDoc
https://t.co/0u8gqiaI4Q

[Ophthalmology @AAOjournal]

New study evaluates the magnitude of visual acuity change with ETDRS vs Snellen testing in clinical trials. This may have implications when interpreting real world VA outcomes. @JasonHsuMD @AtaSalabati @RaziyehMahmoud1 @TXRetinaSurgeon https://t.co/lJzj3InzY8

[Ophthalmology @AAOjournal]

In eyes with primary rhegmatogenous retinal detachment & high risk features for postoperative proliferative vitreoretinopathy, repair with combined vitrectomy & scleral buckling resulted in a higher odds of surgical success. @KhanRetina https://t.co/XqtPwGOsM2

[Ata Salabati, MD @AtaSalabati]

Excited to share our recent paper in @AJOphthalmology. We delve into the outcomes of halting injections in advanced nAMD. Valuable addition to the existing literature led by Katherine Awh, ⁦@RaziyehMahmoud1⁩ and @JasonHsuMD. @MidAtl_Retina @Wills_Eye https://t.co/UJ3jT47xcT